AU6523200A - Vitronectin receptor antagonists useful for the treatment of strokes - Google Patents
Vitronectin receptor antagonists useful for the treatment of strokesInfo
- Publication number
- AU6523200A AU6523200A AU65232/00A AU6523200A AU6523200A AU 6523200 A AU6523200 A AU 6523200A AU 65232/00 A AU65232/00 A AU 65232/00A AU 6523200 A AU6523200 A AU 6523200A AU 6523200 A AU6523200 A AU 6523200A
- Authority
- AU
- Australia
- Prior art keywords
- strokes
- treatment
- receptor antagonists
- vitronectin receptor
- antagonists useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14756799P | 1999-08-06 | 1999-08-06 | |
US60147567 | 1999-08-06 | ||
PCT/US2000/021433 WO2001010867A1 (en) | 1999-08-06 | 2000-08-04 | Vitronectin receptor antagonists useful for the treatment of strokes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6523200A true AU6523200A (en) | 2001-03-05 |
Family
ID=22522092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65232/00A Abandoned AU6523200A (en) | 1999-08-06 | 2000-08-04 | Vitronectin receptor antagonists useful for the treatment of strokes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1208101A4 (en) |
JP (1) | JP2003506452A (en) |
AU (1) | AU6523200A (en) |
WO (1) | WO2001010867A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2244474T3 (en) | 1999-09-29 | 2005-12-16 | Ortho-Mcneil Pharmaceutical, Inc. | ISONIPECOTAMIDE FOR THE TREATMENT OF DISORDERS MEDIATED BY INTEGRINE. |
US7081460B2 (en) | 2001-04-09 | 2006-07-25 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
CN100560131C (en) | 2001-10-22 | 2009-11-18 | 斯克里普斯研究学院 | Antibody targeting compounds |
WO2010093706A2 (en) | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006087A1 (en) * | 1994-08-22 | 1996-02-29 | Smithkline Beecham Corporation | Bicyclic compounds |
JP3960482B2 (en) * | 1995-06-29 | 2007-08-15 | スミスクライン・ビーチャム・コーポレイション | Integrin receptor antagonist |
WO1997024119A1 (en) * | 1995-12-29 | 1997-07-10 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
UA60311C2 (en) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Vitronectin receptor antagonists |
EP1007051A4 (en) * | 1997-08-04 | 2001-08-29 | Smithkline Beecham Corp | Integrin receptor antagonists |
CA2304117A1 (en) * | 1997-09-04 | 1999-03-11 | Dirk A. Heerding | Integrin receptor antagonists |
-
2000
- 2000-08-04 JP JP2001515676A patent/JP2003506452A/en not_active Withdrawn
- 2000-08-04 EP EP00952558A patent/EP1208101A4/en not_active Withdrawn
- 2000-08-04 AU AU65232/00A patent/AU6523200A/en not_active Abandoned
- 2000-08-04 WO PCT/US2000/021433 patent/WO2001010867A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1208101A1 (en) | 2002-05-29 |
JP2003506452A (en) | 2003-02-18 |
WO2001010867A1 (en) | 2001-02-15 |
EP1208101A4 (en) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1425277B8 (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
IL147977A0 (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain | |
PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
HUP0202253A3 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
SI1379647T1 (en) | Antagonist antibodies of a mammalian cytokine or its receptor for the treatment of allergy | |
AU2001271435A1 (en) | Vitronectin receptor antagonist pharmaceuticals | |
AU2003267088A1 (en) | Chemokine receptor antagonists as therapeutic agents | |
AU6990000A (en) | Novel integrin receptor antagonists | |
PL350536A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor | |
HUP0200830A3 (en) | Process for the preparation of substituted pyrimidines | |
GC0000203A (en) | Vitronectin receptor antagonists | |
AU6523200A (en) | Vitronectin receptor antagonists useful for the treatment of strokes | |
AU2003264297A1 (en) | Use of vanilloid receptor antagonists for the treatment of pain | |
WO2000007544A3 (en) | Vitronectin receptor antagonists | |
AU6051200A (en) | Il-8 receptor antagonists | |
AU2002315522A1 (en) | Receptor agonists useful for the treatment of pain | |
AU5748300A (en) | Il-8 receptor antagonists | |
AU5168900A (en) | Il-8 receptor antagonists | |
PL352222A1 (en) | Antagonists of the il-8 receptor | |
AU2003245995A1 (en) | Use of gaba-c receptor antagonists for the treatment of myopia | |
AU2512800A (en) | Alpha1-adrenergic receptor antagonists | |
AU5622400A (en) | Il-8 receptor antagonists | |
SI1200402T1 (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain | |
TW378649U (en) | Structure of the bottle | |
TW382965U (en) | Structure of scalding-proof handle for the wash-free cups |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |